Cover Image

Adult medulloblastoma: updates on current management and future perspectives

Medulloblastoma (MB) is a malignant embryonal tumor of the posterior fossa belonging to the family of primitive neuro-ectodermic tumors (PNET). MB generally occurs in pediatric age, but in 14-30% of cases, it affects the adults, mostly below the age of 40, with an incidence of 0.6 per million per ye...

Full description

Saved in:
Bibliographic Details
Main Authors: Franceschi, Enrico (Author) , Giannini, Caterina (Author) , Furtner, Julia (Author) , Pajtler, Kristian Wilfried (Author) , Asioli, Sofia (Author) , Guzman, Raphael (Author) , Seidel, Clemens (Author) , Gatto, Lidia (Author) , Hau, Peter (Author)
Format: Article (Journal)
Language:English
Published: 29 July 2022
In: Cancers
Year: 2022, Volume: 14, Issue: 15, Pages: 1-21
ISSN:2072-6694
DOI:10.3390/cancers14153708
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers14153708
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/14/15/3708
Get full text
Author Notes:Enrico Franceschi, Caterina Giannini, Julia Furtner, Kristian W. Pajtler, Sofia Asioli, Raphael Guzman, Clemens Seidel, Lidia Gatto and Peter Hau
Description
Summary:Medulloblastoma (MB) is a malignant embryonal tumor of the posterior fossa belonging to the family of primitive neuro-ectodermic tumors (PNET). MB generally occurs in pediatric age, but in 14-30% of cases, it affects the adults, mostly below the age of 40, with an incidence of 0.6 per million per year, representing about 0.4-1% of tumors of the nervous system in adults. Unlike pediatric MB, robust prospective trials are scarce for the post-puberal population, due to the low incidence of MB in adolescent and young adults. Thus, current MB treatments for older patients are largely extrapolated from the pediatric experience, but the transferability and applicability of these paradigms to adults remain an open question. Adult MB is distinct from MB in children from a molecular and clinical perspective. Here, we review the management of adult MB, reporting the recent published literature focusing on the effectiveness of upfront chemotherapy, the development of targeted therapies, and the potential role of a reduced dose of radiotherapy in treating this disease.
Item Description:Gesehen am 10.03.2023
Physical Description:Online Resource
ISSN:2072-6694
DOI:10.3390/cancers14153708

Similar Items